Skip to main content
Erschienen in: Pituitary 2/2020

14.11.2019 | Surgery

National trends in hospital readmission following transsphenoidal surgery for pituitary lesions

verfasst von: Kelly A. Shaftel, Tyler S. Cole, Andrew S. Little

Erschienen in: Pituitary | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Several institutions recently published their experiences with unplanned readmissions rates after transsphenoidal surgery for pituitary lesions. Readmission rates on a national level, however, have not been explored in depth. We investigated nationwide trends in this procedure and associated independent predictors, costs, and causes of 30-day readmission.

Methods

The Nationwide Readmissions Database was queried to identify patients 18 and older who underwent transsphenoidal surgery for pituitary lesion resection (2010–2015). National trends and statistical variances were calculated based on weighted, clustered, and stratified sample means.

Results

Of the weighted total of 44,759 patients treated over the 6-year period, 4658 (10.4%) were readmitted within 30 days. Readmission rates did not change across the survey period (P = 0.71). Patients readmitted had a higher prevalence of comorbidities than those not readmitted (82.5% vs. 78.4%, respectively, P < 0.001), experienced more postoperative complications (47.2% vs. 31.8%, P < 0.001), and had a longer length of stay (6.59 vs. 4.23 days, P < 0.001) during index admission. The most common causes for readmission were SIADH (17.5%) and other hyponatremia (16.4%). Average total readmission cost was $12,080 with no significant trend across the study period (P = 0.25). Predictors for readmission identified included diabetes mellitus, psychological disorders, renal failure, and experiencing diabetes insipidus during the index admission.

Conclusion

Unplanned readmission is an important quality metric. While transsphenoidal pituitary surgery is a relatively safe procedure, 30-day readmission rates and costs have not declined. Future studies on institutional protocols targeting these identified predictors to prevent readmission are necessary to decrease readmission rates on a national scale.
Literatur
1.
Zurück zum Zitat Rizvi ZH, Ferrandino R, Luu Q, Suh JD, Wang MB (2019) Nationwide analysis of unplanned 30-day readmissions after transsphenoidal pituitary surgery. Int Forum Allergy Rhinol 9(3):322–329CrossRef Rizvi ZH, Ferrandino R, Luu Q, Suh JD, Wang MB (2019) Nationwide analysis of unplanned 30-day readmissions after transsphenoidal pituitary surgery. Int Forum Allergy Rhinol 9(3):322–329CrossRef
2.
Zurück zum Zitat Cote DJ, Dasenbrock HH, Muskens IS et al (2017) Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 224(5):971–979CrossRef Cote DJ, Dasenbrock HH, Muskens IS et al (2017) Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 224(5):971–979CrossRef
3.
Zurück zum Zitat Hendricks BL, Shikary TA, Zimmer LA (2016) Causes for 30-day readmission following transsphenoidal surgery. Otolaryngol Head Neck Surg 154(2):359–365CrossRef Hendricks BL, Shikary TA, Zimmer LA (2016) Causes for 30-day readmission following transsphenoidal surgery. Otolaryngol Head Neck Surg 154(2):359–365CrossRef
4.
Zurück zum Zitat Buchanan CC, Hernandez EA, Anderson JM et al (2014) Analysis of 30-day readmissions among neurosurgical patients: surgical complication avoidance as key to quality improvement. J Neurosurg 121(1):170–175CrossRef Buchanan CC, Hernandez EA, Anderson JM et al (2014) Analysis of 30-day readmissions among neurosurgical patients: surgical complication avoidance as key to quality improvement. J Neurosurg 121(1):170–175CrossRef
5.
Zurück zum Zitat Deaver KE, Catel CP, Lillehei KO, Wierman ME, Kerr JM (2018) Strategies to reduce readmissions for hyponatremia after transsphenoidal surgery for pituitary adenomas. Endocrine 62(2):333–339CrossRef Deaver KE, Catel CP, Lillehei KO, Wierman ME, Kerr JM (2018) Strategies to reduce readmissions for hyponatremia after transsphenoidal surgery for pituitary adenomas. Endocrine 62(2):333–339CrossRef
6.
Zurück zum Zitat Bohl MA, Ahmad S, Jahnke H et al (2016) Delayed hyponatremia is the most common cause of 30-day unplanned readmission after transsphenoidal surgery for pituitary tumors. Neurosurgery 78(1):84–90CrossRef Bohl MA, Ahmad S, Jahnke H et al (2016) Delayed hyponatremia is the most common cause of 30-day unplanned readmission after transsphenoidal surgery for pituitary tumors. Neurosurgery 78(1):84–90CrossRef
7.
Zurück zum Zitat Yoon HK, Lee HC, Kim YH, Lim YJ, Park HP (2019) Predictive factors for delayed hyponatremia after endoscopic transsphenoidal surgery in patients with nonfunctioning pituitary tumors: a retrospective observational study. World Neurosurg 122:e1457–e1464CrossRef Yoon HK, Lee HC, Kim YH, Lim YJ, Park HP (2019) Predictive factors for delayed hyponatremia after endoscopic transsphenoidal surgery in patients with nonfunctioning pituitary tumors: a retrospective observational study. World Neurosurg 122:e1457–e1464CrossRef
8.
Zurück zum Zitat Burke WT, Cote DJ, Iuliano SI, Zaidi HA, Laws ER (2018) A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery. Pituitary 21(1):25–31CrossRef Burke WT, Cote DJ, Iuliano SI, Zaidi HA, Laws ER (2018) A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery. Pituitary 21(1):25–31CrossRef
10.
Zurück zum Zitat Zemmoura I, Wierinckx A, Vasiljevic A, Jan M, Trouillas J, Francois P (2013) Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management. Pituitary 16(4):515–522CrossRef Zemmoura I, Wierinckx A, Vasiljevic A, Jan M, Trouillas J, Francois P (2013) Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management. Pituitary 16(4):515–522CrossRef
11.
Zurück zum Zitat Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D (1995) Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55(8):1613–1616PubMed Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D (1995) Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55(8):1613–1616PubMed
12.
Zurück zum Zitat Barnes EL, Kochar B, Long MD et al (2017) modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database. Inflamm Bowel Dis 23(6):875–881CrossRef Barnes EL, Kochar B, Long MD et al (2017) modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database. Inflamm Bowel Dis 23(6):875–881CrossRef
13.
Zurück zum Zitat Bailey KL, Merchant N, Seo YJ, Elashoff D, Benharash P, Yanagawa J (2019) Short-term readmissions after open, thoracoscopic, and robotic lobectomy for lung cancer based on the nationwide readmissions database. World J Surg 43(5):1377–1384CrossRef Bailey KL, Merchant N, Seo YJ, Elashoff D, Benharash P, Yanagawa J (2019) Short-term readmissions after open, thoracoscopic, and robotic lobectomy for lung cancer based on the nationwide readmissions database. World J Surg 43(5):1377–1384CrossRef
14.
Zurück zum Zitat Rumalla K, Smith KA, Arnold PM, Mittal MK (2018) subarachnoid hemorrhage and readmissions: national rates, causes, risk factors, and outcomes in 16,001 hospitalized patients. World Neurosurg 110:e100–e111CrossRef Rumalla K, Smith KA, Arnold PM, Mittal MK (2018) subarachnoid hemorrhage and readmissions: national rates, causes, risk factors, and outcomes in 16,001 hospitalized patients. World Neurosurg 110:e100–e111CrossRef
15.
Zurück zum Zitat Yandrapalli S, Aronow WS, Frishman WH (2018) Readmissions in adult patients following hospitalization for influenza: a nationwide cohort study. Ann Transl Med 6(16):318CrossRef Yandrapalli S, Aronow WS, Frishman WH (2018) Readmissions in adult patients following hospitalization for influenza: a nationwide cohort study. Ann Transl Med 6(16):318CrossRef
17.
Zurück zum Zitat Olson BR, Gumowski J, Rubino D, Oldfield EH (1997) Pathophysiology of hyponatremia after transsphenoidal pituitary surgery. J Neurosurg 87(4):499–507CrossRef Olson BR, Gumowski J, Rubino D, Oldfield EH (1997) Pathophysiology of hyponatremia after transsphenoidal pituitary surgery. J Neurosurg 87(4):499–507CrossRef
18.
Zurück zum Zitat Gross P (2012) Clinical management of SIADH. Ther Adv Endocrinol Metab 3(2):61–73CrossRef Gross P (2012) Clinical management of SIADH. Ther Adv Endocrinol Metab 3(2):61–73CrossRef
19.
Zurück zum Zitat Cavallo LM, Briganti F, Cappabianca P et al (2004) Hemorrhagic vascular complications of endoscopic transsphenoidal surgery. Minim Invasiv Neurosurg 47(3):145–150CrossRef Cavallo LM, Briganti F, Cappabianca P et al (2004) Hemorrhagic vascular complications of endoscopic transsphenoidal surgery. Minim Invasiv Neurosurg 47(3):145–150CrossRef
20.
Zurück zum Zitat Fukushima T, Maroon JC (1998) Repair of carotid artery perforations during transsphenoidal surgery. Surg Neurol 50(2):174–177CrossRef Fukushima T, Maroon JC (1998) Repair of carotid artery perforations during transsphenoidal surgery. Surg Neurol 50(2):174–177CrossRef
21.
Zurück zum Zitat Little AS, Chapple K (2013) Predictors of resource utilization in transsphenoidal surgery for cushing disease. J Neurosurg 119(2):504–511CrossRef Little AS, Chapple K (2013) Predictors of resource utilization in transsphenoidal surgery for cushing disease. J Neurosurg 119(2):504–511CrossRef
22.
Zurück zum Zitat Dardiotis E, Aloizou AM, Markoula S et al (2019) Cancer-associated stroke: pathophysiology, detection and management (review). Int J Oncol 54(3):779–796PubMedPubMedCentral Dardiotis E, Aloizou AM, Markoula S et al (2019) Cancer-associated stroke: pathophysiology, detection and management (review). Int J Oncol 54(3):779–796PubMedPubMedCentral
23.
Zurück zum Zitat Sase T, Wada H, Yamaguchi M et al (2005) Haemostatic abnormalities and thrombotic disorders in malignant lymphoma. Thromb Haemost 93(1):153–159CrossRef Sase T, Wada H, Yamaguchi M et al (2005) Haemostatic abnormalities and thrombotic disorders in malignant lymphoma. Thromb Haemost 93(1):153–159CrossRef
24.
Zurück zum Zitat Levy A (2004) Pituitary disease: presentation, diagnosis, and management. J Neurol Neurosurg Psychiatry 75(Suppl 3):iii47–iii52PubMedPubMedCentral Levy A (2004) Pituitary disease: presentation, diagnosis, and management. J Neurol Neurosurg Psychiatry 75(Suppl 3):iii47–iii52PubMedPubMedCentral
25.
Zurück zum Zitat Le Feuvre CM, Isaacs AJ, Frank OS (1982) Bromocriptine-induced psychosis in acromegaly. Br Med J (Clin Res Ed) 285(6351):1315CrossRef Le Feuvre CM, Isaacs AJ, Frank OS (1982) Bromocriptine-induced psychosis in acromegaly. Br Med J (Clin Res Ed) 285(6351):1315CrossRef
26.
Zurück zum Zitat Melkersson K, Hulting AL (2000) Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder. Eur Arch Psychiatry Clin Neurosci 250(1):6–10CrossRef Melkersson K, Hulting AL (2000) Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder. Eur Arch Psychiatry Clin Neurosci 250(1):6–10CrossRef
27.
Zurück zum Zitat Barber SM, Liebelt BD, Baskin DS (2014) Incidence, etiology and outcomes of hyponatremia after transsphenoidal surgery: experience with 344 consecutive patients at a single tertiary center. J Clin Med 3(4):1199–1219CrossRef Barber SM, Liebelt BD, Baskin DS (2014) Incidence, etiology and outcomes of hyponatremia after transsphenoidal surgery: experience with 344 consecutive patients at a single tertiary center. J Clin Med 3(4):1199–1219CrossRef
28.
Zurück zum Zitat Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88(10):4709–4719CrossRef Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88(10):4709–4719CrossRef
29.
Zurück zum Zitat Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40(2):225–236CrossRef Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40(2):225–236CrossRef
30.
Zurück zum Zitat Shau D, Shenvi N, Easley K, Smith M, Guild G 3rd (2018) Medicaid is associated with increased readmission and resource utilization after primary total knee arthroplasty: a propensity score-matched analysis. Arthroplast Today 4(3):354–358CrossRef Shau D, Shenvi N, Easley K, Smith M, Guild G 3rd (2018) Medicaid is associated with increased readmission and resource utilization after primary total knee arthroplasty: a propensity score-matched analysis. Arthroplast Today 4(3):354–358CrossRef
31.
Zurück zum Zitat Gupta S, Hauser BM, Xu E, Khawaja A, Dunn IF, Wenya LB (2019) Does patient insurance affect readmission for skull base tumors after craniotomy? J Neurol Surg B 80:A108 Gupta S, Hauser BM, Xu E, Khawaja A, Dunn IF, Wenya LB (2019) Does patient insurance affect readmission for skull base tumors after craniotomy? J Neurol Surg B 80:A108
32.
Zurück zum Zitat Sabesan VJ, Petersen-Fitts G, Lombardo D, Briggs D, Whaley J (2017) Medicaid payer status is linked to increased rates of complications after treatment of proximal humerus fractures. J Shoulder Elbow Surg 26(6):948–953CrossRef Sabesan VJ, Petersen-Fitts G, Lombardo D, Briggs D, Whaley J (2017) Medicaid payer status is linked to increased rates of complications after treatment of proximal humerus fractures. J Shoulder Elbow Surg 26(6):948–953CrossRef
33.
Zurück zum Zitat Krings JG, Kallogjeri D, Wineland A, Nepple KG, Piccirillo JF, Getz AE (2015) Complications following primary and revision transsphenoidal surgeries for pituitary tumors. Laryngoscope 125(2):311–317CrossRef Krings JG, Kallogjeri D, Wineland A, Nepple KG, Piccirillo JF, Getz AE (2015) Complications following primary and revision transsphenoidal surgeries for pituitary tumors. Laryngoscope 125(2):311–317CrossRef
Metadaten
Titel
National trends in hospital readmission following transsphenoidal surgery for pituitary lesions
verfasst von
Kelly A. Shaftel
Tyler S. Cole
Andrew S. Little
Publikationsdatum
14.11.2019
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 2/2020
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-019-01007-0

Weitere Artikel der Ausgabe 2/2020

Pituitary 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.